Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
FDA inspection history in Changzhou, China, 2018
- 1
- Form 483
Every document, by year
- Form 483
2018: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at Changzhou, China.
Cited most
Across all Jiangsu Jiaerke Pharmaceuticals Group Corp. observations on file
- 21 CFR 211.194Laboratory records1
The complete Jiangsu Jiaerke Pharmaceuticals Group Corp. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Changzhou, China
One Form 483 · 2018 · 2 observations
Latest: Form 483, Jul 26, 2018 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-07-26 | 483 Form 483 | Changzhou, China | 2 | $99 |
Investigators on these documents
FEI number 3001599766 · most recent document Jul 26, 2018
About Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
How many FDA Form 483s has Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. received?
FDA Intel has 1 Form 483 on file for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.; the most recent is dated Jul 26, 2018.
When was Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. is a Form 483 dated Jul 26, 2018, for the site in Changzhou, China.
What did FDA cite at Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.?
The regulations cited most in the observations on file for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. are 21 CFR 211.194 (Laboratory records), 1 time.